AI assistant
Sending…
HARVARD BIOSCIENCE INC — Director's Dealing 2014
Jun 16, 2014
34975_dirs_2014-06-16_1e385da7-63bf-41b9-ab9a-4f959f6b5494.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-06-16
Reporting Person: Gagnon Robert E. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-16 | Common Stock | P | 5000 | $3.855 | Acquired | 5000 | Direct |
Footnotes
F1: This transaction was executed in two trades at $3.85 and $3.8593. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More from HARVARD BIOSCIENCE INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 23
Major Shareholding Notification
2026
Mar 23
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 17